Fig. 1 · Structure
Documents & Downloads
Butaxamine
β2-adrenoceptor Antagonist
Butaxamine is a selective antagonist of the β2-adrenoceptor, displaying potent activity in inhibiting β2 adrenergic signaling. This compound has demonstrated antiosteoporotic properties, making it a valuable tool in research related to bone density and osteoporosis treatment. Its oral bioavailability enhances its utility in various biological assays and studies focusing on adrenergic signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 2922-20-5 |
| Applications | β2-adrenoceptor Antagonist |
| Formula | C15H25NO3 |
| Molecular Weight | 267.36 |
| Synonyms | Butoxamin |
| SMILES | OC(C1=CC(OC)=CC=C1OC)C(C)NC(C)(C)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.